All In MedTech

Device Trial Radar · NCT01014702

Prospective Clinical Trial of the LensAR Laser System

Prospective Clinical Trial of the LensAR Laser System in the Treatment of Cataracts of Different Grades of Maturity

Last checked: Nov 20, 2026Latest source record: Apr 15, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Nov 2009

Primary completion

Jun 2011

Study completion Jun 2011

Sponsor

Lead sponsor
LensAR IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Nov 17, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The LensAR Laser System is used to create an opening in the anterior capsule of the lens and fragments the cataractous lens. The study will evaluate clinical outcomes compared to the contra-lateral eye treated with conventional phacoemulsification surgery.

Conditions

  • Cataract

Interventions

  • LensAR Laser SystemDevice

    Use of laser for capsulotomy and lens fragmentation

  • Conventional phacoemulsificationDevice

    Use of standard techniques for capsulotomy and lens fragmentation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Completeness and ease of opening of capsulotomyTime frame: Day 0 (Surgery)
  2. Reduced need for ultrasound phacoemulsification compared to control eyeTime frame: Day 0 (surgery)
  3. Rate of adverse eventsTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asociacion para Evitar la Ceguera en Mexico IAP

    Mexico City, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.